The choice between single chamber versus dual chamber pacing for sick sinus syndrome is critically dependent on the relative quality of life achieved by patients with each of these pacing modes, and on the relative cost-effectiveness. The proposed research will analyze health status and other dimensions of quality of life in patients randomized to dual chamber versus single chamber pacing, determine whether there are any differences in the relative benefits of either pacing modality in men versus women or in patients above age 75 years of age versus those less than 75 years of age, and assess the correlation of changes in health status and quality of life with changes in cardiovascular function and with the development of specified cardiovascular events. The research will also measure the comparative costs of the two pacing modes, in terms of both direct and indirect medical cost and non-medical costs, and compare their cost- effectiveness. The quality of life and cost-effectiveness research will be conducted as part of a Core Clinical Proposal which will randomize 2,000 patients in a trial of single chamber versus dual chamber pacing. In addition to the usual clinical outcomes that will be assessed as part of the core proposal, the quality of life and health status core laboratory of the current proposal will assess health status using the Medical Outcomes Study Short Form - 36, and two measures of utility in a subset of 1,400 randomly chosen patients at entry and annually for three years after enrollment. Cost will be determined by use of a detailed questionnaire that will be administered at these same time intervals. The incremental effects of pacing chamber mode on health status, quality of life, and cost-effectiveness determined after controlling for any baseline differences in patient characteristics, co-morbidities, or severity of illness using linear regression analysis. Any incremental differences in health status, quality of life, and cost-effectiveness between the two pacing modes will be compared with the incremental benefits and costs that can be achieved with other alternative allocations of health care resources. Based on the results, it will be expected that recommendations be made regarding preferences for pacing mode from the perspective of both the patient and society.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01HL055981-01
Application #
2234599
Study Section
Special Emphasis Panel (ZHL1-CCT-G (F1))
Project Start
1995-03-01
Project End
2000-02-29
Budget Start
1995-03-01
Budget End
1996-05-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Holmqvist, Fredrik; Hellkamp, Anne S; Lee, Kerry L et al. (2014) Adverse effects of first-degree AV-block in patients with sinus node dysfunction: data from the mode selection trial. Pacing Clin Electrophysiol 37:1111-9
Fleischmann, Kirsten E; Orav, E John; Lamas, Gervasio A et al. (2009) Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). Am Heart J 158:78-83.e2
Fleischmann, Kirsten E; Orav, E John; Lamas, Gervasio A et al. (2006) Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 3:653-9
Shukla, Himanshu H; Hellkamp, Anne S; James, Erskine A et al. (2005) Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration. Heart Rhythm 2:245-51
Rinfret, Stephane; Cohen, David J; Lamas, Gervasio A et al. (2005) Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction. Circulation 111:165-72
Link, Mark S; Hellkamp, Anne S; Estes 3rd, N A Mark et al. (2004) High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol 43:2066-71
Greenspon, Arnold J; Hart, Robert G; Dawson, David et al. (2004) Predictors of stroke in patients paced for sick sinus syndrome. J Am Coll Cardiol 43:1617-22
Flaker, Greg; Greenspon, Arnold; Tardiff, Barbara et al. (2003) Death in patients with permanent pacemakers for sick sinus syndrome. Am Heart J 146:887-93
Glotzer, Taya V; Hellkamp, Anne S; Zimmerman, John et al. (2003) Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 107:1614-9
Lamas, Gervasio A; Lee, Kerry L; Sweeney, Michael O et al. (2002) Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346:1854-62